Call for Abstract
Scientific Program
23rd Asia Pacific Pharma Congress, will be organized around the theme “Future Outlook and Growth of Pharmaceutical Research to Fight Against COVID-19”
Asia Pharma 2020 is comprised of 20 tracks and 105 sessions designed to offer comprehensive sessions that address current issues in Asia Pharma 2020.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Intellectual property (IP) is a category of property that includes intangible creations of the human intellect.Intellectual property encompasses two types of rights: industrial property rights (trademarks, patents, designations of origin, industrial designs and models) and copyright.It was not until the 19th century that the term "intellectual property" began to be used, and not until the late 20th century that it became commonplace in the majority of the world
Regulatory affairs (RA), also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, agrochemicals (plant protection products and fertilizers), energy, banking, telecom etc. Regulatory affairs also has a very specific meaning within the healthcare industries (pharmaceuticals, medical devices, biologics and functional foods).
Regulatory affairs (medical affairs) professionals (aka regulatory professionals) usually have responsibility for the following general areas
Working with federal, state, and local regulatory agencies and personnel on specific issues affecting their business, i.e., working with such agencies as the Food and Drug Administration or European Medicines Agency (pharmaceuticals and medical devices); The Department of Energy; or the Securities and Exchange Commission (banking).
Advising their companies on the regulatory aspects and climate that would affect proposed activities. i.e. describing the "regulatory climate" around issues such as the promotion of prescription drugs and Sarbanes-Oxley compliance.
The Agreement provides norms and standards in respect of following areas of intellectual properties are Patents, Trademarks, copyrights, Geographical indications, Industrial designs.
- Track 1-1Drug Regulations and Organizations
- Track 1-2Regulations and Organizations
- Track 1-3Global Pharma Products Registration
- Track 1-4Intellectual Property Law for Generics and Innovator Rights
- Track 1-5Safety and Quality Regulation in Labelling
- Track 1-6Antimicrobial Activity and Disinfection
Pharmaceutics is the discipline of pharmacy that deals with the process of turning a new chemical entity (NCE) or old drugs into a medication to be used safely and effectively by patients. It is also called the science of dosage form design. There are many chemicals with pharmacological properties, but need special measures to help them achieve therapeutically relevant amounts at their sites of action. Pharmaceutics helps relate the formulation of drugs to their delivery and disposition in the body.Pharmaceutics deals with the formulation of a pure drug substance into a dosage form. Branches of pharmaceutics include Pharmaceutical formulation, Pharmaceutical manufacturing, Dispensing pharmacy, Pharmaceutical technology, Physical pharmacy, Pharmaceutical jurisprudence
Pharmacotherapy is therapy using pharmaceutical drugs,as distinguished from therapy using surgery (surgical therapy), radiation (radiation therapy), movement (physical therapy), or other modes. Among physicians, sometimes the term medical therapy refers specifically to pharmacotherapy as opposed to surgical or other therapy; for example, in oncology, medical oncology is thus distinguished from surgical oncology.
- Track 2-1Pharmacoepidimiology and Pharmacotherapy
- Track 2-2Drug Interactions and Adverse Drug Reactions
- Track 2-3Pre-formulation Considerations
- Track 2-4Pharmaceutical Technology
- Track 2-5Advances in Pharmacodynamics & Pharmacokinetics
- Track 3-1Drug Discovery Research in Pharmacognosy
- Track 3-2Industrial Pharmacognosy
- Track 3-3Drugs from Natural Sources
- Track 3-4Herbal Drug Analysis Methods
- Track 3-5Pharmacoergasy
- Track 4-1Product Management
- Track 4-2Physical Pharmacy Practice
- Track 4-3Post- Marketing Surveillance
- Track 4-4Supply Chain Management
- Track 4-5Good Manufacturing Practices
- Track 4-6Industrial Pharmaceutics
- Track 4-7Drug Discovery and Development
- Track 5-1Nanotechnology in Drug Delivery Systems
- Track 5-2Sustained Drug Delivery System
- Track 5-3Recent Advances in Drug Delivery System
- Track 5-4Pharmaceutical Nanotechnology
- Track 5-5Nanotechnology and Therapeutic Delivery
- Track 6-1Reverse Pharmacology
- Track 6-2Regulatory Toxicology
- Track 6-3Clinical Efficacy and Safety Evaluation
- Track 6-4Drug Interactions and Pharmacological Compatibilities
- Track 6-5Plant Toxicology
<div a="" and="" approaches="" biochemical="" by="" centrally="" chemistry="" combination="" computer-aided="" core="" discipline="" discovery="" div="" drug="" engaged="" focusing="" generally="" in="" is="" it="" known="" lead="" mainly="" medicinal="" molecules="" n="" natural="" of="" on="" optimisation="" organic="" pharmaceutical="" products="" relationship="" sciences.="" structure-activity="" style="\" text-align:"="" synthetic="" technologies="" term="" the="" trans-disciplinary="" using="" which="" within="">
- Track 7-1Chemistry of Natural Products
- Track 7-2Advanced Medicinal Chemistry
- Track 7-3Advances in Pharmaceutical Organic Chemistry
- Track 7-4Molecular Drug Design
- Track 7-5Green Techniques for Organic Synthesis and Medicinal Chemistry
- Track 7-6Advances in Drug Discovery
- Track 7-7Computational Chemistry
- Track 8-1Novel Approaches to Analytical and Bioanalytical Methods
- Track 8-2Bioanalytical Techniques
- Track 8-3Chromatography and Techniques
- Track 8-4Spectroscopic Techniques
- Track 8-5Spectroscopic Techniques
- Track 8-6Nuclear Magnetic Resonanace
- Track 8-7Mass Spectroscopy
- Track 8-8Regulatory Issues and Biosafety Challenges in Bioanalysis
- Track 8-9Applications of Analytical and Bioanalytical Methods
Pharmaceutical Microbiology is an applied branch of Microbiology. It involves the study of microorganisms associated with the manufacture of pharmaceuticals e.g. minimizing the number of microorganisms in a process environment, excluding microorganisms and microbial biproducts like exotoxin and endotoxin from water and other starting materials, and ensuring the finished pharmaceutical product is sterile.Other aspects of pharmaceutical microbiology include the research and development of anti-infective agents, the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and the use of microorganisms in the manufacture of pharmaceutical products like insulin and human growth hormone.
- Track 9-1Microbial Contamination
- Track 9-2Intermediates, APIs, Excipients and Drug Substances
- Track 9-3Critical Microbiology Quality Attributes
- Track 9-4Strategies for Maintaining Non-sterile Manufacturing Environment
- Track 10-1Biomedical Data Engineering
- Track 10-2Bioinformatics Engineering
- Track 10-3Industrial Pharma Biotechnology
- Track 10-4Genetics & Genetic Engineering
- Track 10-5Tissue Engineering
- Track 11-1Computational Chemistry
- Track 11-2Protein Biosynthesis, Protein Folding and Global Protein Analysis and Function
- Track 11-3Biomolecules
- Track 11-4Molecular Drug Design
- Track 11-5Structure Activity Relationship
- Track 11-6Immunochemistry
- Track 12-1Pharmacist Key Role in Treatment
- Track 12-2Role of Clinical Pharmacist
- Track 12-3Challenges in Compounding and Dispensing Pharmacy
- Track 12-4Role of Hospital Pharmacists
- Track 13-1Signal Detection in Drug Safety
- Track 13-2Consulting on Risk Management
- Track 13-3Adverse Event Reporting
- Track 13-4Postmarketing Drug Safety
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy.They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial their approval does not mean that the therapy is safe or effective, only that the trial may be conducted
- Track 14-1Research Methodology
- Track 14-2Recent Updates on Clinical Trials
- Track 14-3Clinical Molecular Genetics
- Track 14-4Clinical Immunology
- Track 14-5Clinical Drug Development and Therapeutics
- Track 14-6Clinical Research and Methodology
- Track 15-1Cancer Pharmcogenetics
- Track 15-2Recent Advances in DNA Repair
- Track 15-3Methods To Determine Biological Targeting
- Track 15-4T Cell Modulation and Immune Response
- Track 15-5Mutagenecity and Genotoxicity
- Track 16-1Good Governance in Pharmacy
- Track 16-2Ethics in Pharmacy
- Track 16-3Future Trends in Green Pharmacy
- Track 16-4Role of Community Pharmacist
- Track 16-5Green Technologies in Pharmaceutical Industry
A nutraceutical is a pharmaceutical- and standardized nutrient.In the US, "nutraceuticals" do not exist as a regulatory category; they are regulated as dietary supplements and food additives by the FDA under the authority of the Federal Food, Drug, and Cosmetic Act.Nutraceuticals are usually natural substances and, unlike drugs, are not substances synthesized for a certain purpose .Nutraceuticals are also called functional foods, which are defined as “food products to be taken as part of the usual diet in order to have beneficial effects that go beyond basic nutritional function”.Nutraceutical product is a food or fortified food product that not only supplements the diet but also assists in treating or preventing disease (apart from anemia), so provides medical benefits.Nutraceuticals are not tested and regulated to the extent of pharmaceutical drugs. The word nutraceutical is combined from the words nutrition and pharmaceutical.
- Track 17-1Herbal & Traditional Medicine
- Track 17-2Natural Medicine Products
- Track 17-3Nutraceuticals in Cancer Therapy
- Track 17-4Dietary Supplements & Functional Foods
- Track 17-5Prebiotics & Probiotics
- Track 18-1Clinical Practice Guidelines
- Track 18-2Patient Centered Pharmacy Practice
- Track 18-3Global Technical Standards
- Track 18-4Critical View of Pharmacy Education
Pharmaceutical Care is the pharmacologist/pharmacist’s contribution to the care of individuals in order to optimize medicines use and improve health outcomes’.The ultimate goal of pharmaceutical care (optimize medicines use and improving health outcomes) exists in all practice settings and in all cultures where medicines are used. It involves two major functions: identifying potential and manifest problems in the pharmacotherapy (DRPs), and then resolving the problems and preventing the potential problems from becoming real for the patient and his therapy outcomes. This should preferably be done together with other health care professionals and the patient through a review of the medication (and diseases) and subsequent counselling and discussions
- Track 19-1Pharmaceutical Care Management
- Track 19-2Health Care Management and Providers
- Track 19-3Medical Billing Softwares
- Track 19-4Medication Management Services
- Track 20-1Regulatory Compliance
- Track 20-2Risk Management
- Track 20-3Patient Compliance
- Track 20-4Data Integration